

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.91663739 |
| 2 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 9.74540798 |
| 3 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 9.74540798 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.50804027 |
| 5 | B cell receptor signaling pathway (GO:0050853) | 5.97727797 |
| 6 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.88612405 |
| 7 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.49145158 |
| 8 | * regulation of B cell receptor signaling pathway (GO:0050855) | 5.20290383 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 5.09420740 |
| 10 | cellular response to exogenous dsRNA (GO:0071360) | 5.05344491 |
| 11 | negative regulation of gene silencing (GO:0060969) | 4.87181280 |
| 12 | T cell migration (GO:0072678) | 4.77283935 |
| 13 | regulation of B cell differentiation (GO:0045577) | 4.75465953 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.70135017 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.64876876 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.63998953 |
| 17 | regulation of germinal center formation (GO:0002634) | 4.49037949 |
| 18 | regulation of chromatin silencing (GO:0031935) | 4.47558117 |
| 19 | negative thymic T cell selection (GO:0045060) | 4.45692341 |
| 20 | negative regulation of B cell apoptotic process (GO:0002903) | 4.43874006 |
| 21 | DNA demethylation (GO:0080111) | 4.41616127 |
| 22 | cellular response to zinc ion (GO:0071294) | 4.38830379 |
| 23 | regulation of antigen processing and presentation (GO:0002577) | 4.34214717 |
| 24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.33991368 |
| 25 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.27999673 |
| 26 | somatic diversification of immunoglobulins (GO:0016445) | 4.26482270 |
| 27 | negative regulation of cell killing (GO:0031342) | 4.24309526 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.24309526 |
| 29 | T cell lineage commitment (GO:0002360) | 4.24243856 |
| 30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.18953540 |
| 31 | negative T cell selection (GO:0043383) | 4.15256799 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15005181 |
| 33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.11815501 |
| 34 | type I interferon signaling pathway (GO:0060337) | 4.00547095 |
| 35 | cellular response to type I interferon (GO:0071357) | 4.00547095 |
| 36 | response to type I interferon (GO:0034340) | 3.98806329 |
| 37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.98508721 |
| 38 | regulation of B cell apoptotic process (GO:0002902) | 3.94176705 |
| 39 | regulation of phospholipase A2 activity (GO:0032429) | 3.93759189 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.92916444 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.91433248 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.90648823 |
| 43 | B cell mediated immunity (GO:0019724) | 3.90521816 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90512035 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90512035 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.89667290 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88216143 |
| 48 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.87273052 |
| 49 | intracellular pH reduction (GO:0051452) | 3.82608469 |
| 50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81325705 |
| 51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81325705 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 3.81325705 |
| 53 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81325705 |
| 54 | modulation by symbiont of host defense response (GO:0052031) | 3.81325705 |
| 55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81325705 |
| 56 | germinal center formation (GO:0002467) | 3.78629762 |
| 57 | telomere maintenance via recombination (GO:0000722) | 3.76893782 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76103228 |
| 59 | response to interleukin-15 (GO:0070672) | 3.75664464 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70169123 |
| 61 | mast cell activation (GO:0045576) | 3.68298829 |
| 62 | pinocytosis (GO:0006907) | 3.67606551 |
| 63 | ribosomal small subunit assembly (GO:0000028) | 3.67406600 |
| 64 | DNA dealkylation (GO:0035510) | 3.65766379 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 3.65031998 |
| 66 | regulation of B cell proliferation (GO:0030888) | 3.64975714 |
| 67 | histamine secretion (GO:0001821) | 3.64051272 |
| 68 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60694934 |
| 69 | positive regulation of humoral immune response (GO:0002922) | 3.55033611 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.54388335 |
| 71 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.53414305 |
| 72 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.50622212 |
| 73 | positive regulation of B cell proliferation (GO:0030890) | 3.48572732 |
| 74 | T cell costimulation (GO:0031295) | 3.47484959 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.44941377 |
| 76 | T-helper 1 type immune response (GO:0042088) | 3.44425834 |
| 77 | lymphocyte homeostasis (GO:0002260) | 3.43783175 |
| 78 | lymphocyte costimulation (GO:0031294) | 3.42555078 |
| 79 | B cell proliferation (GO:0042100) | 3.41573996 |
| 80 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.40738815 |
| 81 | isotype switching (GO:0045190) | 3.40738815 |
| 82 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.40738815 |
| 83 | defense response to protozoan (GO:0042832) | 3.39016531 |
| 84 | cellular response to interferon-beta (GO:0035458) | 3.38946168 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 3.38657916 |
| 86 | DNA strand elongation (GO:0022616) | 3.38609134 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 3.37382447 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 3.37297598 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 3.36363749 |
| 90 | thymic T cell selection (GO:0045061) | 3.34470481 |
| 91 | positive T cell selection (GO:0043368) | 3.32777258 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 3.29629557 |
| 93 | mitotic recombination (GO:0006312) | 3.29217352 |
| 94 | positive regulation of protein homooligomerization (GO:0032464) | 3.27333714 |
| 95 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.26296979 |
| 96 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.25414518 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 3.19873308 |
| 98 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.19146589 |
| 99 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.19088040 |
| 100 | T cell selection (GO:0045058) | 3.18847453 |
| 101 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.15494508 |
| 102 | positive regulation of neutrophil migration (GO:1902624) | 3.15494508 |
| 103 | cellular response to interferon-gamma (GO:0071346) | 3.15437206 |
| 104 | somatic diversification of immune receptors (GO:0002200) | 3.14668275 |
| 105 | microglial cell activation (GO:0001774) | 3.14148225 |
| 106 | tolerance induction (GO:0002507) | 3.13569946 |
| 107 | B cell homeostasis (GO:0001782) | 3.11938365 |
| 108 | B cell activation involved in immune response (GO:0002312) | 3.11313855 |
| 109 | telomere maintenance via telomere lengthening (GO:0010833) | 3.10948710 |
| 110 | positive regulation of macrophage cytokine production (GO:0060907) | 3.10847819 |
| 111 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07116712 |
| 112 | cellular response to dsRNA (GO:0071359) | 3.07094121 |
| 113 | positive regulation of B cell mediated immunity (GO:0002714) | 3.05301279 |
| 114 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.05301279 |
| 115 | response to host immune response (GO:0052572) | 3.04684683 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04684683 |
| 117 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.04323242 |
| 118 | pH reduction (GO:0045851) | 3.03152419 |
| 119 | detection of bacterium (GO:0016045) | 3.03140196 |
| 120 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.02946841 |
| 121 | natural killer cell mediated immunity (GO:0002228) | 3.02946841 |
| 122 | mature B cell differentiation (GO:0002335) | 3.01404788 |
| 123 | T cell homeostasis (GO:0043029) | 3.01079288 |
| 124 | negative regulation of B cell proliferation (GO:0030889) | 2.98700566 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97789414 |
| 126 | negative regulation of bone resorption (GO:0045779) | 2.96641188 |
| 127 | regulation of B cell activation (GO:0050864) | 2.96508096 |
| 128 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96385370 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.95634294 |
| 130 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.92974676 |
| 131 | regulation of alpha-beta T cell activation (GO:0046634) | 2.90833332 |
| 132 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.89791647 |
| 133 | leukocyte homeostasis (GO:0001776) | 2.89650126 |
| 134 | lymphocyte proliferation (GO:0046651) | 2.89335457 |
| 135 | respiratory burst (GO:0045730) | 2.89207713 |
| 136 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89156213 |
| 137 | response to protozoan (GO:0001562) | 2.89132825 |
| 138 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88279393 |
| 139 | positive regulation of B cell activation (GO:0050871) | 2.87989961 |
| 140 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86975876 |
| 141 | B cell activation (GO:0042113) | 2.86545047 |
| 142 | macrophage activation involved in immune response (GO:0002281) | 2.85771808 |
| 143 | mononuclear cell proliferation (GO:0032943) | 2.85652570 |
| 144 | histamine transport (GO:0051608) | 2.85285426 |
| 145 | sphingolipid catabolic process (GO:0030149) | 2.84720800 |
| 146 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84658525 |
| 147 | response to host (GO:0075136) | 2.84658525 |
| 148 | response to host defenses (GO:0052200) | 2.84658525 |
| 149 | megakaryocyte development (GO:0035855) | 2.81427136 |
| 150 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.79684041 |
| 151 | actin nucleation (GO:0045010) | 2.78839116 |
| 152 | cytidine metabolic process (GO:0046087) | 12.6854183 |
| 153 | cytidine catabolic process (GO:0006216) | 12.6854183 |
| 154 | cytidine deamination (GO:0009972) | 12.6854183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.53945998 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.76606291 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.25899465 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.20017489 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.65215529 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.28255803 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.19094086 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13887376 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.09008004 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95509894 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87868008 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86630274 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.57869001 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.57505478 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.56288463 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.36283399 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22356296 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22193260 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18994921 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.18303429 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14028664 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13255033 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.12600809 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08700677 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02161901 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.01174816 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99718110 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.99390157 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95260949 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92261375 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90409124 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86095595 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82817561 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81567925 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.76713823 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74340596 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73128621 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70450112 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69859270 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67846939 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.65921504 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65161985 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65148071 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63038822 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53534859 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53027500 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52758082 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44908428 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44908112 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43346202 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43296264 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41365074 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40861804 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40057598 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36249589 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33982700 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32661009 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30807529 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30637523 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30205517 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27607697 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26728256 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25472777 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24285376 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23691407 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23302388 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22119766 |
| 68 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20858746 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20680907 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17556290 |
| 71 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16485890 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15024398 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13217731 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12910077 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.12720967 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12624804 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12590090 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11166486 |
| 79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08560242 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06083076 |
| 81 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03940291 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03397909 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03179732 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01705235 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01164602 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01078502 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00776028 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00351608 |
| 89 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99863103 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99754410 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98820646 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98647318 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94268665 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93815291 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93607645 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92951821 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92926177 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91130681 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86749319 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86396198 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85949518 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 0.85896975 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84425366 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82884192 |
| 105 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.82123709 |
| 106 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81831649 |
| 107 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.81631589 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81365901 |
| 109 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.80805758 |
| 110 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.80208748 |
| 111 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80207990 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80124642 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80000529 |
| 114 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79715609 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79390896 |
| 116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78400416 |
| 117 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78061783 |
| 118 | GATA3_26560356_Chip-Seq_TH1_Human | 0.77780817 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77683819 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76593080 |
| 121 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.76590562 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.74281416 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73887858 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72344447 |
| 125 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.72307032 |
| 126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71719359 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71667497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 7.99703533 |
| 2 | MP0005671_abnormal_response_to | 4.43681234 |
| 3 | MP0001800_abnormal_humoral_immune | 4.23108670 |
| 4 | MP0001790_abnormal_immune_system | 3.91617745 |
| 5 | MP0005387_immune_system_phenotype | 3.91617745 |
| 6 | MP0000685_abnormal_immune_system | 3.70257004 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.60356963 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.10094117 |
| 9 | MP0001819_abnormal_immune_cell | 3.03902653 |
| 10 | MP0002420_abnormal_adaptive_immunity | 3.00286673 |
| 11 | MP0002723_abnormal_immune_serum | 2.96781912 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.82111994 |
| 13 | MP0006082_CNS_inflammation | 2.75686560 |
| 14 | MP0004510_myositis | 2.68653244 |
| 15 | MP0009785_altered_susceptibility_to | 2.65168074 |
| 16 | MP0002398_abnormal_bone_marrow | 2.59410847 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.48738589 |
| 18 | MP0005025_abnormal_response_to | 2.47376635 |
| 19 | MP0000716_abnormal_immune_system | 2.39380336 |
| 20 | MP0008057_abnormal_DNA_replication | 2.37699578 |
| 21 | MP0010094_abnormal_chromosome_stability | 2.31069934 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.27498588 |
| 23 | MP0002419_abnormal_innate_immunity | 2.14793086 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.10968528 |
| 25 | MP0002933_joint_inflammation | 2.10358936 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 2.06714113 |
| 27 | MP0001853_heart_inflammation | 2.01214505 |
| 28 | MP0002429_abnormal_blood_cell | 1.98501672 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.91686171 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.88714048 |
| 31 | MP0002405_respiratory_system_inflammati | 1.85901419 |
| 32 | MP0002722_abnormal_immune_system | 1.85845244 |
| 33 | MP0005310_abnormal_salivary_gland | 1.75153356 |
| 34 | MP0003436_decreased_susceptibility_to | 1.75127067 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.74762040 |
| 36 | MP0003724_increased_susceptibility_to | 1.74496410 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.63303318 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.59490648 |
| 39 | MP0003303_peritoneal_inflammation | 1.56500099 |
| 40 | MP0002009_preneoplasia | 1.46904820 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.43525166 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.40881067 |
| 43 | MP0002006_tumorigenesis | 1.36233184 |
| 44 | MP0004381_abnormal_hair_follicle | 1.27673096 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.24954506 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.23796793 |
| 47 | MP0002163_abnormal_gland_morphology | 1.21605192 |
| 48 | MP0004947_skin_inflammation | 1.17580072 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.17203537 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.16938509 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.16741660 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.16609290 |
| 53 | MP0003077_abnormal_cell_cycle | 1.14885934 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.13980953 |
| 55 | MP0003111_abnormal_nucleus_morphology | 1.13929976 |
| 56 | MP0003866_abnormal_defecation | 1.13296658 |
| 57 | MP0000681_abnormal_thyroid_gland | 1.08404764 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.06233068 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.05639191 |
| 60 | MP0006054_spinal_hemorrhage | 0.98526678 |
| 61 | MP0004957_abnormal_blastocyst_morpholog | 0.98110201 |
| 62 | MP0008007_abnormal_cellular_replicative | 0.97326149 |
| 63 | MP0009764_decreased_sensitivity_to | 0.94778612 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 0.92999806 |
| 65 | MP0005623_abnormal_meninges_morphology | 0.89789465 |
| 66 | MP0008469_abnormal_protein_level | 0.88417485 |
| 67 | MP0008058_abnormal_DNA_repair | 0.88396462 |
| 68 | MP0005174_abnormal_tail_pigmentation | 0.85367131 |
| 69 | MP0003091_abnormal_cell_migration | 0.83806180 |
| 70 | MP0000372_irregular_coat_pigmentation | 0.82685645 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.81883960 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.81455638 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.78682505 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.78682505 |
| 75 | MP0000490_abnormal_crypts_of | 0.78193743 |
| 76 | MP0001873_stomach_inflammation | 0.75537227 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.74159635 |
| 78 | MP0001191_abnormal_skin_condition | 0.73934043 |
| 79 | MP0003252_abnormal_bile_duct | 0.70758683 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.69792201 |
| 81 | MP0002090_abnormal_vision | 0.67460687 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.64889397 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.64336730 |
| 84 | MP0004147_increased_porphyrin_level | 0.63049245 |
| 85 | MP0000371_diluted_coat_color | 0.61751378 |
| 86 | MP0001727_abnormal_embryo_implantation | 0.61362557 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.59932116 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.59422835 |
| 89 | MP0008874_decreased_physiological_sensi | 0.58704960 |
| 90 | MP0003045_fibrosis | 0.58173582 |
| 91 | MP0005621_abnormal_cell_physiology | 0.57623814 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.57357536 |
| 93 | MP0008260_abnormal_autophagy | 0.56431432 |
| 94 | MP0010307_abnormal_tumor_latency | 0.56002169 |
| 95 | MP0000609_abnormal_liver_physiology | 0.55896980 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.54584060 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.54466238 |
| 98 | MP0003868_abnormal_feces_composition | 0.53862021 |
| 99 | MP0000858_altered_metastatic_potential | 0.53203168 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.52154736 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.51790068 |
| 102 | MP0009046_muscle_twitch | 0.50101974 |
| 103 | MP0009697_abnormal_copulation | 0.48644610 |
| 104 | MP0000313_abnormal_cell_death | 0.48219669 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.48138746 |
| 106 | MP0001186_pigmentation_phenotype | 0.46464799 |
| 107 | MP0002083_premature_death | 0.46226962 |
| 108 | MP0009379_abnormal_foot_pigmentation | 0.45660149 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.44398200 |
| 110 | MP0000249_abnormal_blood_vessel | 0.42957746 |
| 111 | MP0001851_eye_inflammation | 0.42621371 |
| 112 | MP0005451_abnormal_body_composition | 0.41219012 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.40539712 |
| 114 | MP0009115_abnormal_fat_cell | 0.40220761 |
| 115 | MP0005166_decreased_susceptibility_to | 0.39895169 |
| 116 | MP0009763_increased_sensitivity_to | 0.39726628 |
| 117 | MP0000598_abnormal_liver_morphology | 0.39151004 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.39035695 |
| 119 | MP0002928_abnormal_bile_duct | 0.39019798 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.35992349 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.35033188 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.34952273 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34654296 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.34631871 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.33430621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.78008010 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 6.96612615 |
| 3 | Recurrent sinusitis (HP:0011108) | 5.89012494 |
| 4 | IgA deficiency (HP:0002720) | 5.87892500 |
| 5 | Recurrent bronchitis (HP:0002837) | 5.58703613 |
| 6 | Recurrent lower respiratory tract infections (HP:0002783) | 5.24678209 |
| 7 | IgG deficiency (HP:0004315) | 5.17629554 |
| 8 | Chronic otitis media (HP:0000389) | 5.01066260 |
| 9 | Lymphopenia (HP:0001888) | 4.89835505 |
| 10 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.86614171 |
| 11 | Chronic sinusitis (HP:0011109) | 4.78403055 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.76661367 |
| 13 | Cellulitis (HP:0100658) | 4.72988507 |
| 14 | IgM deficiency (HP:0002850) | 4.72307523 |
| 15 | Recurrent pneumonia (HP:0006532) | 4.54083236 |
| 16 | Meningitis (HP:0001287) | 4.33498751 |
| 17 | Vasculitis (HP:0002633) | 4.27441103 |
| 18 | Emphysema (HP:0002097) | 4.25946458 |
| 19 | Colitis (HP:0002583) | 4.24827135 |
| 20 | Recurrent abscess formation (HP:0002722) | 4.12608929 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 4.10206739 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 4.04958175 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.99769460 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88964264 |
| 25 | Recurrent viral infections (HP:0004429) | 3.64968315 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.60970404 |
| 27 | Loss of speech (HP:0002371) | 3.53954006 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.47157186 |
| 29 | Osteomyelitis (HP:0002754) | 3.38938962 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.33892086 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.31540195 |
| 32 | Autoimmune hemolytic anemia (HP:0001890) | 3.29858152 |
| 33 | Restrictive lung disease (HP:0002091) | 3.29779917 |
| 34 | Papilloma (HP:0012740) | 3.22530066 |
| 35 | Verrucae (HP:0200043) | 3.22530066 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18501046 |
| 37 | Lymphoma (HP:0002665) | 3.17276495 |
| 38 | Thyroiditis (HP:0100646) | 3.17099530 |
| 39 | Basal cell carcinoma (HP:0002671) | 3.02009469 |
| 40 | Thrombocytosis (HP:0001894) | 3.01598209 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 2.99704979 |
| 42 | Bronchitis (HP:0012387) | 2.96104200 |
| 43 | Recurrent otitis media (HP:0000403) | 2.92597608 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92409798 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92409798 |
| 46 | Skin rash (HP:0000988) | 2.92396194 |
| 47 | Leukopenia (HP:0001882) | 2.91813802 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89025023 |
| 49 | Obstructive lung disease (HP:0006536) | 2.89025023 |
| 50 | Recurrent fungal infections (HP:0002841) | 2.88776336 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.85955920 |
| 52 | Recurrent skin infections (HP:0001581) | 2.79734270 |
| 53 | Prostate neoplasm (HP:0100787) | 2.75808420 |
| 54 | Sepsis (HP:0100806) | 2.75626558 |
| 55 | Poor head control (HP:0002421) | 2.75190033 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.71383056 |
| 57 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.70855015 |
| 58 | Abnormality of T cells (HP:0002843) | 2.69828750 |
| 59 | Xerostomia (HP:0000217) | 2.68380439 |
| 60 | Increased IgM level (HP:0003496) | 2.62789256 |
| 61 | Progressive microcephaly (HP:0000253) | 2.61266532 |
| 62 | Abnormality of male internal genitalia (HP:0000022) | 2.59859277 |
| 63 | Squamous cell carcinoma (HP:0002860) | 2.48121229 |
| 64 | Hypertensive crisis (HP:0100735) | 2.42793920 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40139094 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.38078998 |
| 67 | Chronic diarrhea (HP:0002028) | 2.37620920 |
| 68 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36368069 |
| 69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35197771 |
| 70 | Abnormality of T cell number (HP:0011839) | 2.34874227 |
| 71 | Paralysis (HP:0003470) | 2.33562129 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.33224781 |
| 73 | Viral hepatitis (HP:0006562) | 2.32725709 |
| 74 | Fatigue (HP:0012378) | 2.30662656 |
| 75 | Aplastic anemia (HP:0001915) | 2.29924545 |
| 76 | Absent epiphyses (HP:0010577) | 2.27687406 |
| 77 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.27687406 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.27152928 |
| 79 | Optic neuritis (HP:0100653) | 2.25372986 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.25372986 |
| 81 | Poikiloderma (HP:0001029) | 2.24637195 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.24385105 |
| 83 | Encephalitis (HP:0002383) | 2.22942410 |
| 84 | Small epiphyses (HP:0010585) | 2.22290234 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 2.21061359 |
| 86 | Hepatitis (HP:0012115) | 2.19933481 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.19907563 |
| 88 | Nasal polyposis (HP:0100582) | 2.16818860 |
| 89 | Abnormality of DNA repair (HP:0003254) | 2.12156882 |
| 90 | Arthralgia (HP:0002829) | 2.10392621 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.10130440 |
| 92 | Acute hepatic failure (HP:0006554) | 2.07413863 |
| 93 | Abnormality of the fingertips (HP:0001211) | 2.06775598 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.06151788 |
| 95 | Abnormality of B cell number (HP:0010975) | 2.05824781 |
| 96 | B lymphocytopenia (HP:0010976) | 2.05824781 |
| 97 | Chest pain (HP:0100749) | 2.04016511 |
| 98 | Cerebral palsy (HP:0100021) | 2.03298695 |
| 99 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02371246 |
| 100 | Villous atrophy (HP:0011473) | 2.02371246 |
| 101 | Neutropenia (HP:0001875) | 2.01702586 |
| 102 | Hemoptysis (HP:0002105) | 2.01519512 |
| 103 | Skin ulcer (HP:0200042) | 1.99277105 |
| 104 | Eosinophilia (HP:0001880) | 1.97901029 |
| 105 | Teleangiectasia of the skin (HP:0100585) | 1.93579989 |
| 106 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89898643 |
| 107 | Granulocytopenia (HP:0001913) | 1.89598546 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88868992 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88868992 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88868992 |
| 111 | Carpal bone hypoplasia (HP:0001498) | 1.88195605 |
| 112 | Acrocyanosis (HP:0001063) | 1.87127223 |
| 113 | Clubbing of toes (HP:0100760) | 1.86546044 |
| 114 | Increased IgE level (HP:0003212) | 1.86274547 |
| 115 | Spontaneous hematomas (HP:0007420) | 1.85285454 |
| 116 | Large eyes (HP:0001090) | 1.84424842 |
| 117 | T lymphocytopenia (HP:0005403) | 1.84330051 |
| 118 | Mucosal telangiectasiae (HP:0100579) | 1.83831312 |
| 119 | Myositis (HP:0100614) | 1.82622138 |
| 120 | Pulmonary fibrosis (HP:0002206) | 1.82449617 |
| 121 | Limb hypertonia (HP:0002509) | 1.81156154 |
| 122 | Bronchiectasis (HP:0002110) | 1.80788973 |
| 123 | Orchitis (HP:0100796) | 1.80175610 |
| 124 | Urticaria (HP:0001025) | 1.77922839 |
| 125 | Hypochromic anemia (HP:0001931) | 1.76441103 |
| 126 | Abnormality of eosinophils (HP:0001879) | 1.74490699 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.71840106 |
| 128 | Macular degeneration (HP:0000608) | 1.70001133 |
| 129 | Abnormality of macrophages (HP:0004311) | 1.68682982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.50746581 |
| 2 | CSF1R | 4.13429665 |
| 3 | KIT | 3.96680139 |
| 4 | BLK | 3.58111056 |
| 5 | PRPF4B | 3.42073910 |
| 6 | FLT3 | 3.10638353 |
| 7 | MAP3K10 | 2.58990556 |
| 8 | * SYK | 2.54100546 |
| 9 | TXK | 2.49132456 |
| 10 | PRKCH | 2.44108451 |
| 11 | BTK | 2.36418166 |
| 12 | TEC | 2.36137031 |
| 13 | ITK | 2.33556048 |
| 14 | GRK1 | 2.08333543 |
| 15 | TBK1 | 1.99915863 |
| 16 | BMPR2 | 1.97070901 |
| 17 | SMG1 | 1.95892229 |
| 18 | PRKCQ | 1.91864874 |
| 19 | MAP3K14 | 1.87279462 |
| 20 | PRKCI | 1.83140987 |
| 21 | * LYN | 1.79801681 |
| 22 | TLK1 | 1.73905391 |
| 23 | SIK2 | 1.67805087 |
| 24 | ACVR1B | 1.65202607 |
| 25 | CDC7 | 1.63399413 |
| 26 | PASK | 1.62680216 |
| 27 | CCNB1 | 1.56343354 |
| 28 | IRAK4 | 1.54823703 |
| 29 | CLK1 | 1.54776788 |
| 30 | TYK2 | 1.45111945 |
| 31 | STK24 | 1.36884378 |
| 32 | IKBKB | 1.35267697 |
| 33 | ZAP70 | 1.29115015 |
| 34 | LRRK2 | 1.28619842 |
| 35 | SIK3 | 1.28408252 |
| 36 | CDK4 | 1.23783000 |
| 37 | STK10 | 1.20735798 |
| 38 | NUAK1 | 1.20019694 |
| 39 | EEF2K | 1.16178530 |
| 40 | VRK1 | 1.15184138 |
| 41 | RIPK4 | 1.14552020 |
| 42 | LCK | 1.12858485 |
| 43 | FGFR4 | 1.12018396 |
| 44 | HCK | 1.11711376 |
| 45 | BUB1 | 1.10444011 |
| 46 | MAP2K2 | 1.07107373 |
| 47 | MST4 | 1.00359762 |
| 48 | EIF2AK1 | 0.98203643 |
| 49 | JAK1 | 0.97505402 |
| 50 | CSK | 0.96485912 |
| 51 | MAP3K12 | 0.93276516 |
| 52 | CSNK1G1 | 0.93098407 |
| 53 | JAK3 | 0.91733073 |
| 54 | MAPK7 | 0.90027948 |
| 55 | GRK6 | 0.88993627 |
| 56 | TAOK3 | 0.86371228 |
| 57 | BRSK1 | 0.85614620 |
| 58 | MAP3K13 | 0.85449785 |
| 59 | IKBKE | 0.83168342 |
| 60 | PRKCD | 0.82631954 |
| 61 | NEK9 | 0.81285475 |
| 62 | MATK | 0.78977255 |
| 63 | BMPR1B | 0.77564965 |
| 64 | CDK19 | 0.74802824 |
| 65 | TAF1 | 0.73117825 |
| 66 | ADRBK2 | 0.69917756 |
| 67 | RPS6KB2 | 0.68901544 |
| 68 | MAPK12 | 0.68826577 |
| 69 | JAK2 | 0.68478069 |
| 70 | FES | 0.67661450 |
| 71 | TGFBR1 | 0.65866880 |
| 72 | RPS6KA5 | 0.63549452 |
| 73 | ERN1 | 0.61782868 |
| 74 | MELK | 0.61777546 |
| 75 | CSNK1G3 | 0.61230895 |
| 76 | BCR | 0.60998329 |
| 77 | CSNK1A1L | 0.59062022 |
| 78 | EIF2AK3 | 0.58387804 |
| 79 | SRPK1 | 0.55992078 |
| 80 | MAPK4 | 0.54676414 |
| 81 | PIK3CG | 0.53927251 |
| 82 | ATR | 0.52693053 |
| 83 | TRIB3 | 0.52659856 |
| 84 | BRD4 | 0.51096616 |
| 85 | PRKCE | 0.49348214 |
| 86 | ABL1 | 0.49233000 |
| 87 | DAPK3 | 0.49109351 |
| 88 | TRPM7 | 0.48830293 |
| 89 | MAP3K8 | 0.48343260 |
| 90 | TESK2 | 0.44940847 |
| 91 | PIM1 | 0.44238849 |
| 92 | PDK1 | 0.44188178 |
| 93 | NEK1 | 0.42095194 |
| 94 | STK4 | 0.40949301 |
| 95 | FGR | 0.40863251 |
| 96 | EIF2AK2 | 0.40563708 |
| 97 | CDC42BPA | 0.40369702 |
| 98 | MARK3 | 0.39426050 |
| 99 | TAOK2 | 0.39043538 |
| 100 | TNK2 | 0.38992265 |
| 101 | BRSK2 | 0.38473337 |
| 102 | MAPK11 | 0.37985294 |
| 103 | PRKCZ | 0.37963195 |
| 104 | AURKB | 0.37876678 |
| 105 | HIPK2 | 0.36966847 |
| 106 | PRKCG | 0.35159864 |
| 107 | CHUK | 0.34861131 |
| 108 | CDK9 | 0.34532869 |
| 109 | PIM2 | 0.33841808 |
| 110 | RPS6KA4 | 0.33152138 |
| 111 | SCYL2 | 0.33122687 |
| 112 | MAPKAPK2 | 0.32946061 |
| 113 | FYN | 0.32108313 |
| 114 | IGF1R | 0.30409589 |
| 115 | MAP3K9 | 0.29602420 |
| 116 | ALK | 0.29310842 |
| 117 | CHEK1 | 0.28173730 |
| 118 | KDR | 0.28141772 |
| 119 | MYLK | 0.28007162 |
| 120 | MAPKAPK3 | 0.27725060 |
| 121 | CHEK2 | 0.26385494 |
| 122 | PTK2B | 0.25489405 |
| 123 | MUSK | 0.24891781 |
| 124 | INSR | 0.24770993 |
| 125 | TGFBR2 | 0.24759987 |
| 126 | FGFR3 | 0.24143338 |
| 127 | ARAF | 0.24087770 |
| 128 | DAPK1 | 0.23765884 |
| 129 | NEK2 | 0.22966233 |
| 130 | MAPK13 | 0.22299523 |
| 131 | NLK | 0.22165800 |
| 132 | DAPK2 | 0.22143213 |
| 133 | MAP2K6 | 0.21439712 |
| 134 | RPS6KC1 | 0.21130821 |
| 135 | CSNK2A1 | 0.20607597 |
| 136 | CDK12 | 0.20463653 |
| 137 | STK16 | 0.19692594 |
| 138 | CDK8 | 0.19523612 |
| 139 | CSNK1G2 | 0.19288486 |
| 140 | ZAK | 0.19077016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.72790103 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.39934630 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 4.06473709 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.95933936 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.54224508 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 3.52914414 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.78182903 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.57048068 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.27488764 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26864211 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17506994 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.15065635 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07609908 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04571865 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.01302354 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72669937 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.68963462 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56804021 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.56603094 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50319585 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48286279 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39890075 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.33815333 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33547489 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.29235078 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26737849 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26649182 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.25896769 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22428155 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22375062 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20327163 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12588369 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12306597 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.07572675 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.05396979 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04431883 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02761861 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97773352 |
| 39 | Alcoholism_Homo sapiens_hsa05034 | 0.97631912 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93168068 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92556102 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90560815 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89829220 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86953889 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86372966 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85595164 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84749171 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 0.83880113 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83147970 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81658337 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80888104 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79235356 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77389597 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.77141396 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.77006889 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.76465670 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.75616524 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.75289547 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.73912427 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.68386212 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67422416 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67107269 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61310843 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.61048158 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58031620 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55639917 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.53431301 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.52988349 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51497924 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50061952 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49831499 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.49758155 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49340982 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46042889 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45862352 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45072223 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.43864606 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.43408296 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42435590 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40123302 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38564640 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36546544 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33494302 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33352526 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32595932 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32298145 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31906090 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31166623 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28552141 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24855974 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24608690 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.24351999 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.24182917 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23399444 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23322431 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.21925947 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.21918815 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20853765 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20102236 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19802600 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18434455 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17449620 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17177663 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.16992818 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14587669 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.14084437 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.13974855 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.13350477 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.12498336 |
| 110 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.12264732 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11853220 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11825484 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11809198 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11564875 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11361018 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10130644 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.08863422 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.08236796 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.05478424 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01589986 |

